Related Experiment Video
Updated: Aug 6, 2026

Evaluation of Mammary Gland Development and Function in Mouse Models
Published on: July 21, 2011
Vanadate disrupts mammary gland development in whole organ culture
E Gallo-Hendrikx1, S A Murray, B K Vonderhaar
1Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA.
Abstract:
Protein tyrosine kinases and phosphatases are signaling molecules involved in all aspects of development, including proliferation, differentiation, and apoptosis. How disruption of protein tyrosine phosphatase affects mammary gland development is not entirely clear. We examined the effects of sodium vanadate, which is known to primarily inhibit tyrosine phosphatases, in mouse mammary gland development in whole organ culture. Mammary epithelial differentiation was effectively inhibited by vanadate in a dose-dependent manner as indicated by lack of epithelial alveoli compared to the contralateral non-treated gland controls. Mammary glands in the differentiation medium after four days in the presence of vanadate did not differentiate into alveoli. Instead, they exhibited prominent terminal end buds and lost the distinctive epithelial structures. The inhibitory effect of vanadate on mammary epithelial cell differentiation was irreversible after one day of treatment. Immunohistochemical staining for PCNA (Proliferating Cell Nuclear Antigen) showed that vanadate-treated glands exhibited elevated proliferation signals in the differentiation medium. Expression of beta-casein protein in the vanadate-treated glands decreased dramatically and progressively. Short-term exposure (up to 72 hours) of mammary glands to vanadate resulted in an increase in mammary epithelial cell density and loss of organization of the mammary structures. TUNEL assay of mammary glands with prolonged exposure to vanadate revealed widespread apoptosis. Furthermore, some cells were still proliferating or expressing beta-casein after prolonged exposure to vanadate. Taken together, these data indicate that vanadate treatment blocks mammary epithelial cell differentiation and promotes abnormal proliferation and apoptosis, likely through the inhibition of protein tyrosine phosphatase-mediated signaling.
Insights
Sodium vanadate inhibits protein tyrosine phosphatase (PTP) activity, blocking mammary gland epithelial cell differentiation. This disruption leads to abnormal proliferation, apoptosis, and altered mammary structures, impacting development.
Area of Science:
- Cellular signaling
- Developmental biology
- Biochemistry
Background:
- Protein tyrosine kinases and phosphatases are crucial for cellular processes like proliferation and differentiation.
- The specific impact of protein tyrosine phosphatase disruption on mammary gland development remains unclear.
Purpose of the Study:
- To investigate the effects of sodium vanadate, a tyrosine phosphatase inhibitor, on mouse mammary gland development in vitro.
- To elucidate the role of tyrosine phosphatases in mammary epithelial differentiation and morphogenesis.
Main Methods:
- Whole mouse mammary organ culture treated with varying doses of sodium vanadate.
- Immunohistochemical staining for Proliferating Cell Nuclear Antigen (PCNA).
- Assessment of beta-casein expression and TUNEL assay for apoptosis.
Main Results:
- Vanadate treatment inhibited mammary epithelial differentiation in a dose-dependent manner, preventing alveoli formation.
- Observed increased cell proliferation (PCNA+), decreased beta-casein expression, and loss of epithelial structure.
- Short-term vanadate exposure increased cell density, while prolonged exposure induced widespread apoptosis.
Conclusions:
- Sodium vanadate effectively blocks mammary epithelial cell differentiation, likely by inhibiting protein tyrosine phosphatase signaling.
- Vanadate treatment promotes abnormal proliferation and apoptosis, disrupting normal mammary gland development.
- The inhibitory effects on differentiation were found to be irreversible after one day of treatment.

